Amelin AV, Tereshchenko NM, Gotovchikov AA. [Clinical experience with the use of a fixed combination of diclofenac and orphenadrine in the treatment of acute pain syndrome].
Zh Nevrol Psikhiatr Im S S Korsakova 2021;
121:83-86. [PMID:
34481441 DOI:
10.17116/jnevro202112108183]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants (MR) are successfully used to relieve pain, both in monotherapy and in combinations. The use of fixed drug combinations not only greatly facilitates daily clinical practice and increases patient adherence, but due to the potentiation of pharmacological effects, it allows to achieve better treatment results. This paper presents 3 clinical cases of successful inpatient use of a fixed combination of diclofenac 75 mg and orphenadrine 30 mg in the form of an infusion solution (NEODOLPASSE) for relief of acute back musculoskeletal pain syndrome.
Collapse